CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
General and administrative	$ 3,120,060	$ 1,385,981
Research and development	2,006,214	321,377
Total operating expenses	5,126,274	1,707,358
Loss from operations	(5,126,274)	(1,707,358)
Other income
Finance income	23,866	0
Total other income	23,866	0
Net loss and comprehensive loss for the year	$ (5,102,408)	$ (1,707,358)
Net loss per share attributable to common shareholders - basic	$ (0.42)	$ (0.21)
Net loss per share attributable to common shareholders - diluted	$ (0.42)	$ (0.21)
Weighted average number of common shares outstanding - basic	12,240,437	8,076,673
Weighted average number of common shares outstanding - diluted	12,240,437	8,076,673